From Our Partners
Wednesday, July 6, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Botulinum Neurotoxin Assay Contract to Fluoresentric

by Global Biodefense Staff
June 12, 2013

The Centers for Disease Control and Prevention has announced intentions to solicit and enter into a sole source contract with Fluoresentric, Inc. for botulinum toxin assays.

The CbotA (16,000Rxn) and Cbot A (50,000 Rxn) real-time PCR singleplex assays developed by the Fluoresentric, Inc. are noted to be the only assays that can be utilized with existing, validated platforms for detection of botulinum toxin genes. 

“The PCR assays are required for support of federal, state, and local public health laboratories to detect Clostridium botulinum using existing protocols and platforms,” states the announcement. “In order to ensure that the assays perform as required, the assays must contain the identical oligonucleotide sequence and have the same specificity and sensitivity as that developed by Fluoresentric.”

Fluoresentric, Inc. is based in Park City, Utah.

The contract is on behalf of the CDC National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne and Environmental Diseases (DFWED), Enteric Diseases Laboratory Branch (EDLB).

Editor’s Note: While the small-scale procurement of laboratory equipment or reagents is commonplace, we periodically cover these activities for insight into the research, acquisition and mission priorities of biodefense-relevant organizations.

From Our Partners
Tags: Botulinum Neurotoxin

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC